AC
CGNX icon

Armistice Capital’s Cognex CGNX Stock Holding History

Armistice Capital’s Portfolio CGNX Stock Details CGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,242
Closed -$297K – 299
2025
Q4 		$297K Buy
+8,242
New +$334K ﹤0.01% 278

Other funds holding CGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Armistice Capital's CGNX Position: Q1 2026 in Review

Armistice Capital sold out of Cognex (CGNX) in Q1 2026, closing a stake of 8,242 shares — an estimated $297K sold.

Armistice Capital first reported a position in CGNX in Q4 2025 and held it in 1 quarter. The position peaked at $297K in Q4 2025. 569 funds tracked by Wall St. Rank hold CGNX as of Q1 2026.

  • Armistice Capital reported no remaining Cognex position as of Q1 2026 after selling out during the quarter.
  • Armistice Capital sold 8,242 Cognex shares in Q1 2026, an estimated $297K.
  • Armistice Capital first reported a position in Cognex in Q4 2025 and held it in 1 quarter.
  • Armistice Capital's Cognex position peaked at $297K in Q4 2025.
  • 569 funds tracked by Wall St. Rank held Cognex as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.